Tony Kouzarides

Wellcome Trust/CR-UK Gurdon Institute of Cancer and Developmental Biology, University of Cambridge, UK

Tony Kouzarides Picture Tony Kouzarides is the Royal Society Napier Professor, a chair endowed specifically for Cancer Research. Tony is a Senior Group Leader and Deputy Director of the Gurdon Institute, and is affiliated to the Department of Pathology of Cambridge University. His interests lie in chromatin modification and their role in transcription and cancer.

Tony Kouzarides is a member of the European Molecular Biology organisation and a member of Cancer Research UK’s Science and Strategy Advisory Group. He is a founder of Chroma therapeutics, a cancer drug discovery company in Oxford, which has as its focus enzymes that modify chromatin. He is also a founder and Director of AbCam, an antibody reagents company in Cambridge.